vs

Side-by-side financial comparison of BALCHEM CORP (BCPC) and Waystar Holding Corp. (WAY). Click either name above to swap in a different company.

Waystar Holding Corp. is the larger business by last-quarter revenue ($313.9M vs $270.7M, roughly 1.2× BALCHEM CORP). BALCHEM CORP runs the higher net margin — 14.9% vs 13.8%, a 1.1% gap on every dollar of revenue. On growth, Waystar Holding Corp. posted the faster year-over-year revenue change (22.4% vs 8.1%). Waystar Holding Corp. produced more free cash flow last quarter ($90.3M vs $33.8M). Over the past eight quarters, Waystar Holding Corp.'s revenue compounded faster (15.7% CAGR vs 7.5%).

Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.

Waystar Holding Corp is a leading provider of integrated healthcare payment and revenue cycle management solutions. It serves healthcare providers, health systems, and payers across the United States, offering tools that streamline billing, claims processing, patient payment collection, and revenue optimization to reduce administrative burdens and improve financial performance for healthcare organizations.

BCPC vs WAY — Head-to-Head

Bigger by revenue
WAY
WAY
1.2× larger
WAY
$313.9M
$270.7M
BCPC
Growing faster (revenue YoY)
WAY
WAY
+14.3% gap
WAY
22.4%
8.1%
BCPC
Higher net margin
BCPC
BCPC
1.1% more per $
BCPC
14.9%
13.8%
WAY
More free cash flow
WAY
WAY
$56.4M more FCF
WAY
$90.3M
$33.8M
BCPC
Faster 2-yr revenue CAGR
WAY
WAY
Annualised
WAY
15.7%
7.5%
BCPC

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BCPC
BCPC
WAY
WAY
Revenue
$270.7M
$313.9M
Net Profit
$40.3M
$43.3M
Gross Margin
Operating Margin
20.5%
25.6%
Net Margin
14.9%
13.8%
Revenue YoY
8.1%
22.4%
Net Profit YoY
8.7%
47.9%
EPS (diluted)
$1.25
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCPC
BCPC
WAY
WAY
Q1 26
$270.7M
$313.9M
Q4 25
$263.6M
$303.5M
Q3 25
$267.6M
$268.7M
Q2 25
$255.5M
$270.7M
Q1 25
$250.5M
$256.4M
Q4 24
$240.0M
$244.1M
Q3 24
$239.9M
$240.1M
Q2 24
$234.1M
$234.5M
Net Profit
BCPC
BCPC
WAY
WAY
Q1 26
$40.3M
$43.3M
Q4 25
$39.2M
$20.0M
Q3 25
$40.3M
$30.6M
Q2 25
$38.3M
$32.2M
Q1 25
$37.1M
$29.3M
Q4 24
$33.6M
$19.1M
Q3 24
$33.8M
$5.4M
Q2 24
$32.1M
$-27.7M
Gross Margin
BCPC
BCPC
WAY
WAY
Q1 26
Q4 25
35.6%
Q3 25
35.7%
Q2 25
36.4%
Q1 25
35.2%
Q4 24
36.0%
Q3 24
35.6%
Q2 24
35.5%
Operating Margin
BCPC
BCPC
WAY
WAY
Q1 26
20.5%
25.6%
Q4 25
19.8%
19.4%
Q3 25
20.4%
22.4%
Q2 25
20.1%
24.0%
Q1 25
20.4%
25.4%
Q4 24
19.8%
21.8%
Q3 24
20.0%
11.3%
Q2 24
19.6%
3.5%
Net Margin
BCPC
BCPC
WAY
WAY
Q1 26
14.9%
13.8%
Q4 25
14.9%
6.6%
Q3 25
15.1%
11.4%
Q2 25
15.0%
11.9%
Q1 25
14.8%
11.4%
Q4 24
14.0%
7.8%
Q3 24
14.1%
2.3%
Q2 24
13.7%
-11.8%
EPS (diluted)
BCPC
BCPC
WAY
WAY
Q1 26
$1.25
$0.42
Q4 25
$1.21
$0.10
Q3 25
$1.24
$0.17
Q2 25
$1.17
$0.18
Q1 25
$1.13
$0.16
Q4 24
$1.03
$0.18
Q3 24
$1.03
$0.03
Q2 24
$0.98
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCPC
BCPC
WAY
WAY
Cash + ST InvestmentsLiquidity on hand
$72.9M
$34.3M
Total DebtLower is stronger
$13.5M
Stockholders' EquityBook value
$1.3B
$3.9B
Total Assets
$1.7B
$5.8B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCPC
BCPC
WAY
WAY
Q1 26
$72.9M
$34.3M
Q4 25
$74.6M
$61.4M
Q3 25
$65.1M
$421.1M
Q2 25
$65.4M
$290.3M
Q1 25
$49.9M
$224.0M
Q4 24
$49.5M
$182.1M
Q3 24
$73.7M
$127.1M
Q2 24
$63.7M
$68.4M
Total Debt
BCPC
BCPC
WAY
WAY
Q1 26
$13.5M
Q4 25
$1.5B
Q3 25
Q2 25
Q1 25
Q4 24
$1.2B
Q3 24
Q2 24
Stockholders' Equity
BCPC
BCPC
WAY
WAY
Q1 26
$1.3B
$3.9B
Q4 25
$1.3B
$3.9B
Q3 25
$1.3B
$3.2B
Q2 25
$1.3B
$3.2B
Q1 25
$1.2B
$3.1B
Q4 24
$1.1B
$3.1B
Q3 24
$1.2B
$3.1B
Q2 24
$1.1B
$2.9B
Total Assets
BCPC
BCPC
WAY
WAY
Q1 26
$1.7B
$5.8B
Q4 25
$1.7B
$5.8B
Q3 25
$1.7B
$4.7B
Q2 25
$1.7B
$4.7B
Q1 25
$1.6B
$4.6B
Q4 24
$1.6B
$4.6B
Q3 24
$1.6B
$4.5B
Q2 24
$1.6B
$4.6B
Debt / Equity
BCPC
BCPC
WAY
WAY
Q1 26
0.00×
Q4 25
0.38×
Q3 25
Q2 25
Q1 25
Q4 24
0.40×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCPC
BCPC
WAY
WAY
Operating Cash FlowLast quarter
$40.1M
$84.9M
Free Cash FlowOCF − Capex
$33.8M
$90.3M
FCF MarginFCF / Revenue
12.5%
28.8%
Capex IntensityCapex / Revenue
2.3%
Cash ConversionOCF / Net Profit
0.99×
1.96×
TTM Free Cash FlowTrailing 4 quarters
$314.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCPC
BCPC
WAY
WAY
Q1 26
$40.1M
$84.9M
Q4 25
$67.3M
$66.6M
Q3 25
$65.6M
$82.0M
Q2 25
$47.3M
$96.8M
Q1 25
$36.5M
$64.2M
Q4 24
$52.3M
Q3 24
$51.3M
$78.8M
Q2 24
$45.0M
$15.4M
Free Cash Flow
BCPC
BCPC
WAY
WAY
Q1 26
$33.8M
$90.3M
Q4 25
$57.2M
Q3 25
$76.2M
Q2 25
$91.0M
Q1 25
$58.8M
Q4 24
Q3 24
$70.2M
Q2 24
$8.6M
FCF Margin
BCPC
BCPC
WAY
WAY
Q1 26
12.5%
28.8%
Q4 25
18.9%
Q3 25
28.3%
Q2 25
33.6%
Q1 25
22.9%
Q4 24
Q3 24
29.2%
Q2 24
3.7%
Capex Intensity
BCPC
BCPC
WAY
WAY
Q1 26
2.3%
Q4 25
3.1%
Q3 25
2.2%
Q2 25
2.1%
Q1 25
2.1%
Q4 24
Q3 24
3.6%
Q2 24
2.9%
Cash Conversion
BCPC
BCPC
WAY
WAY
Q1 26
0.99×
1.96×
Q4 25
1.72×
3.33×
Q3 25
1.63×
2.68×
Q2 25
1.23×
3.01×
Q1 25
0.98×
2.20×
Q4 24
1.56×
Q3 24
1.52×
14.56×
Q2 24
1.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BCPC
BCPC

Segment breakdown not available.

WAY
WAY

Subscription$172.2M55%
Volume-based$139.5M44%

Related Comparisons